Zhejiang Hisoar Pharmaceutical Co., Ltd.

Chine


Commandez votre montre hebdomadaire Zhejiang Hisoar Pharmaceutical Co., Ltd.
Quantité totale PI 13
Rang # Quantité totale PI 119 585
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 344 322
Symbole boursier 002099 (szse)
ISIN CNE000001PY2
Capitalisation 9.7B  (CNY)
Industrie Drug Manufacturers - Major
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

2 1
0 1
7 2
0
 
Dernier brevet 2024 - Lifitegrast morpholine salt, met...
Premier brevet 2010 - Intermediate of cilastatin and p...
Dernière marque 2020 - H HISOAR
Première marque 2013 - P

Filiales

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Lifitegrast morpholine salt, method for preparing same, and use thereof. The present invention re...
2020 P/S Ketones; leather-waterproofing chemicals; acetate esters; active chemical ingredients for use in ...
P/S Esters, namely, Clindamycin palmitate hydrochloride, Bifendate and beta-Methyl vinyl phosphate; k...
P/S Esters; ketones; industrial chemicals; diagnostic preparations, other than for medical or veteri...
2015 Invention Preparation method for nebivolol intermediate and preparation method for nebivolol. Provided is a...
2013 P/S Medicines for human purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; ...
2012 Invention Preparation method of amorolfine hydrochloride. A preparation method of amorolfine hydrochloride ...
Invention Method for preparing anhydrous crystal form i of sitagliptin phosphate. The present invention rel...
2011 Invention Intermediates of sitagliptin and preparation process thereof. Disclosed are intermediates of Sita...
2010 Invention An amorolfine hcl crystal and the preparation thereof. This invention relates to an Amorolfine HC...
Invention Intermediate of cilastatin and preparation method thereof. Disclosed is a method for preparing 7-...